Organization | Pancreatic Cancer Action Network

Pancreatic Cancer Action Network Report issue

Foundation Phase 1 Phase 2 Phase 3

Founded: Manhattan Beach CA United States (1999)

Organization Overview

First Clinical Trial

2017

NCT03848182

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Pancreatic Cancer Action Network | Pancreatic Cancer Action Network (PCAN)

Active Ingredients

Drugs in Phase 3 Trials (7)

fluorouracil (efudex) (1 trial)

gemcitabine (gemzar) (3 trials)

irinotecan (Camptosar) (1 trial)

leucovorin (1 trial)

oxaliplatin (eloxatin) (1 trial)

paclitaxel (taxol) (2 trials)

sm-88 (1 trial)

Drugs in Phase 2 Trials (2)

multitaa t cells (1 trial)

tetanus toxoid (1 trial)

Drugs in Phase 1 Trials (2)

canakinumab (ilaris) (1 trial)

spartalizumab (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Adenocarcinoma (Phase 3)

Pancreatic Neoplasms (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 4
# of Trial APIs: 11